109 related articles for article (PubMed ID: 16422458)
21. Stent thrombosis after primary angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy over time: results of the HORIZONS-AMI trial.
Dangas GD; Claessen BE; Mehran R; Xu K; Stone GW
EuroIntervention; 2013 Jan; 8(9):1033-9. PubMed ID: 23339809
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.
Marcucci R; Paniccia R; Antonucci E; Gori AM; Fedi S; Giglioli C; Valente S; Prisco D; Abbate R; Gensini GF
Am J Cardiol; 2006 Nov; 98(9):1156-9. PubMed ID: 17056317
[TBL] [Abstract][Full Text] [Related]
23. Resolution of a spontaneous coronary artery thrombus with a new antiplatelet agent.
Dagdelen S; Soydinc S; Ergelen M; Caglar N
Int Angiol; 2001 Sep; 20(3):244-7. PubMed ID: 11573060
[TBL] [Abstract][Full Text] [Related]
24. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
25. Reactive thrombocytosis leading to acute myocardial infarction.
Aundhakar SC; Mahajan SK; Mane MB; Lakhotiya AN
J Assoc Physicians India; 2013 Oct; 61(10):745-7. PubMed ID: 24772734
[TBL] [Abstract][Full Text] [Related]
26. Aspirin in coronary artery disease: an appraisal of functions and limitations.
Würtz M
Dan Med J; 2015 Apr; 62(4):B5011. PubMed ID: 25872543
[TBL] [Abstract][Full Text] [Related]
27. [Myocardial infarction caused by thrombosis of the left coronary artery in a patient with thrombocythemia].
Joseph T; Hiltgen M; Gaulier A; Saudemont JP
Ann Cardiol Angeiol (Paris); 1996 Dec; 45(10):581-4. PubMed ID: 9033696
[TBL] [Abstract][Full Text] [Related]
28. Current antiplatelet therapy for Japanese patients with ST elevation acute myocardial infarction: J-AMI registry.
Nakamura M; Yamagishi M; Ueno T; Hara K; Ishiwata S; Itoh T; Hamanaka I; Wakatsuki T; Sugano T; Kawai K; Kimura T
Cardiovasc Interv Ther; 2013 Apr; 28(2):162-9. PubMed ID: 23233418
[TBL] [Abstract][Full Text] [Related]
29. Myocardial infarction and primary thrombocytosis in a young man.
Gabriel L; de Meester A
Acta Cardiol; 2003 Feb; 58(1):35-7. PubMed ID: 12625493
[TBL] [Abstract][Full Text] [Related]
30. Successful trapping of an organized thrombus in a coronary artery aneurysm in myocardial infarction: case report and literature review.
Härle T; Reimers J; Hertting K; Kuck KH
Cardiovasc Revasc Med; 2008; 9(1):52-5. PubMed ID: 18206639
[TBL] [Abstract][Full Text] [Related]
31. Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets.
Würtz M; Grove EL; Wulff LN; Kaltoft AK; Tilsted HH; Jensen LO; Hvas AM; Kristensen SD
JACC Cardiovasc Interv; 2010 Aug; 3(8):828-35. PubMed ID: 20723855
[TBL] [Abstract][Full Text] [Related]
32. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.
Matetzky S; Shenkman B; Guetta V; Shechter M; Beinart R; Goldenberg I; Novikov I; Pres H; Savion N; Varon D; Hod H
Circulation; 2004 Jun; 109(25):3171-5. PubMed ID: 15184279
[TBL] [Abstract][Full Text] [Related]
33. Point-of-care testing of clopidogrel-mediated platelet inhibition and risk for cardiovascular events after coronary angiography with or without percutaneous coronary intervention.
Holm M; Dalén M; Tornvall P; van der Linden J
Blood Coagul Fibrinolysis; 2014 Sep; 25(6):577-84. PubMed ID: 24614428
[TBL] [Abstract][Full Text] [Related]
34. Do we need antiplatelet therapy in thrombocytosis? Contra. Proposal for an individualized risk-adapted treatment.
Scharf RE
Hamostaseologie; 2016 Nov; 36(4):241-260. PubMed ID: 27414763
[TBL] [Abstract][Full Text] [Related]
35. Drug-specific thienopyridine resistance in patient with recurrent coronary stent thrombosis.
Milicic D; Skoric B; Lovric D
J Invasive Cardiol; 2009 Aug; 21(8):E157-60. PubMed ID: 19652267
[TBL] [Abstract][Full Text] [Related]
36. Clinical impact of enhanced inhibition of P2Y12-mediated platelet aggregation in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Capranzano P; Mehran R; Tamburino C; Stone GW; Dangas G
Hosp Pract (1995); 2010 Nov; 38(4):38-43. PubMed ID: 21068525
[TBL] [Abstract][Full Text] [Related]
37. Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Chen KY; Rha SW; Li YJ; Poddar KL; Jin Z; Minami Y; Wang L; Kim EJ; Park CG; Seo HS; Oh DJ; Jeong MH; Ahn YK; Hong TJ; Kim YJ; Hur SH; Seong IW; Chae JK; Cho MC; Bae JH; Choi DH; Jang YS; Chae IH; Kim CJ; Yoon JH; Chung WS; Seung KB; Park SJ;
Circulation; 2009 Jun; 119(25):3207-14. PubMed ID: 19528339
[TBL] [Abstract][Full Text] [Related]
38. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden.
Sianos G; Papafaklis MI; Daemen J; Vaina S; van Mieghem CA; van Domburg RT; Michalis LK; Serruys PW
J Am Coll Cardiol; 2007 Aug; 50(7):573-83. PubMed ID: 17692740
[TBL] [Abstract][Full Text] [Related]
39. [Myocardial infarction in 22 year-old male with essential thrombocythaemia].
Müllertz KM; Vestergaard H; Hansen HS
Ugeskr Laeger; 2011 Feb; 173(8):585-6. PubMed ID: 21333260
[TBL] [Abstract][Full Text] [Related]
40. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Claeys MJ; Cools F; Hill KA; Skene AM; McCabe CH; Braunwald E;
N Engl J Med; 2005 Mar; 352(12):1179-89. PubMed ID: 15758000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
